The relationship between serum lactate dehydrogenase level and mortality in critically ill patients

Biomark Med. 2021 Jun;15(8):551-559. doi: 10.2217/bmm-2020-0671. Epub 2021 May 14.

Abstract

Background: To assess the association between serum lactate dehydrogenase (LDH) levels and mortality in intensive care unit patients. Materials & methods: A total of 1981 patients in the eICU Collaborative Research Database were divided into four groups according to quartiles of LDH levels. Logistic regressions were performed. Results: Elevated LDH levels were significantly associated with higher mortality (intensive care unit mortality: Q2 vs Q1: 1.046 [0.622-1.758]; Q3 vs Q1: 1.667 [1.029-2.699]; and Q4 vs Q1: 1.760 [1.092-2.839]). Similar results persisted in patients with different acute physiology and chronic health evaluation IV scores, and with or without sepsis. Conclusion: The serum LDH level may aid in the early identification of mortality risk in critically ill patients.

Keywords: eICU Collaborative Research Database intensive care unit; lactate dehydrogenase; mortality.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood*
  • Critical Illness / mortality*
  • Female
  • Follow-Up Studies
  • Hospital Mortality / trends*
  • Humans
  • Intensive Care Units / statistics & numerical data*
  • Lactate Dehydrogenases / blood*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Assessment / methods*
  • Survival Rate

Substances

  • Biomarkers
  • Lactate Dehydrogenases